GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.41 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 90,000 | $295,200 | 0.31% |
Greenlight Capital | 588,410 | $1,929,985 | 0.11% |
PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $190,568 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $148,903 | 0.00% |
Householder Group Estate & Retirement Specialist, LLC | 2,500 | $8,200 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HM PAYSON & CO | 1,000 | $3,280 | 0.00% |
GROUP ONE TRADING, L.P. | 1,937 | $6,257 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 151,476 | $489,355 | 0.00% |
MORGAN STANLEY | 1,300 | $4,264 | 0.00% |
BlackRock Inc. | 27,925 | $91,594 | 0.00% |
Citadel Advisors | 1,700 | $5,491 | 0.00% |
Citadel Advisors | 4,100 | $13,243 | 0.00% |
Citadel Advisors | 45,876 | $148,179 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 65,226 | $210,680 | 0.00% |
SIMPLEX TRADING, LLC | 8,650 | $28 | 0.00% |
Tower Research Capital LLC (TRC) | 2,870 | $9,414 | 0.00% |
Renaissance Technologies | 46,900 | $154 | 0.00% |
ROYAL BANK OF CANADA | 210,000 | $689,000 | 0.00% |
VANGUARD GROUP INC | 70,280 | $230,518 | 0.00% |
External links
This page lists GAIN THERAPEUTICS INC's shareholders in Q3 2023. To view GAIN THERAPEUTICS INC's shareholder history, click here.